$ALEC 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The Company's immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer's disease. This scientific approach is also the basis for the Company's immuno-oncology programs.

CEO

Arnon Rosenthal

Exchange

NASDAQ

Website

alector.com

$198M

Total Revenue

171

Employees

$2B

Market Capitalization

-44.68

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Moderna Inc MRNA 127530 11831 12.07 18.50 59.68
AMGEN Inc. AMGN 116380 25767 13.80 20.76 21.77
Gilead Sciences, Inc. GILD 88272 27482 4.07 11.87 26.90
Biogen Inc BIIB 35597 11101 3.32 22.56 13.93
Seagen Inc SGEN 27585 1746 8.71 -81.48 -19.06
Bio-Techne Corp TECH 19158 985 11.20 107.91 17.93
Repligen Corp. RGEN 15323 593 8.67 128.01 20.06
Novavax, Inc. NVAX 13293 1182 31.58 -13.52 -80.37
Acceleron Pharma Inc XLRN 10904 113 15.23 -42.36 -226.00
Neurocrine Biosciences, Inc. NBIX 7903 1069 5.68 17.76 41.59
CRISPR Therapeutics AG CRSP 5811 902 2.27 15.14 45.64
Denali Therapeutics Inc DNLI 5353 353 5.17 83.96 8.38
Fate Therapeutics Inc FATE 4892 55 6.88 -24.69 -359.67
Halozyme Therapeutics Inc. HALO 4877 463 16.59 11.89 88.36
China Biologic Products Holdin CBPO 4680 514 2.35 33.71 27.09
Kodiak Sciences Inc KOD 4571 6.38 -20.60 None
Beam Therapeutics Inc BEAM 4426 1 5.79 -10.77 None
Soaring Eagle Acquisition Corp SRNG 3860 None None None
Adaptive Biotechnologies Corp ADPT 3646 147 5.68 -19.29 -129.95
NantKwest Inc NK 3379 0 30.36 -36.51 -969.27
SpringWorks Therapeutics Inc SWTX 3363 35 7.39 -32.90 -304.47
Palisade Bio Inc PALI 2978 27705 0.07 0.51 21.16
Translate Bio Inc TBIO 2877 225 6.84 64.41 17.97
Relay Therapeutics Inc RLAY 2708 85 5.57 22.30 -306.80
Iovance Biotherapeutics Inc IOVA 2659 3.96 -8.51 None
Biocryst Pharmaceuticals Inc. BCRX 2056 114 -14.09 -9.09 -270.53
Revolution Medicines Inc RVMD 1963 29 3.19 -11.67 -587.91
Editas Medicine Inc EDIT 1952 24 3.45 -8.99 -871.91
Trillium Therapeutics Inc TRIL 1899 0 7.95 -36.16 None
Nanostring Technologies Inc NSTG 1745 139 8.89 -16.09 -78.48
C4 Therapeutics Inc CCCC 1733 34 4.31 -5.90 -234.53
Vericel Corp VCEL 1717 154 10.68 3577.00 0.14
Alector Inc ALEC 1612 198 4.76 -44.68 -16.62
Heska Corp. HSKA 1603 250 3.95 593.67 0.75
Atara Biotherapeutics Inc ATRA 1580 13 4.95 -4.81 None
Inhibrx Inc INBX 1515 7 53.86 -21.78 -742.82
Krystal Biotech Inc KRYS 1487 3.86 -26.13 None
Celldex Therapeutics Inc. CLDX 1445 8 3.77 -19.69 -891.92
Coherus Biosciences Inc CHRS 1409 364 10.62 -5.79 -63.72
ITeos Therapeutics Inc ITOS 1298 104 3.32 26.77 14.14
Regenxbio Inc RGNX 1297 93 2.93 -6.13 -228.08
Sangamo Therapeutics Inc SGMO 1217 109 3.03 -6.65 -167.16
Vaxcyte Inc PCVX 1064 3.53 -15.16 None
BioAtla Inc BCAB 818 0 3.53 -9.18 -4.66
Gritstone Bio Inc GRTS 818 46 3.99 -9.54 -155.87
Immunovant Inc IMVT 801 0 1.70 -6.24 None
Vaxart Inc VXRT 789 1 4.10 -12.39 -796.34
Prevail Therapeutics Inc PRVL 759 6.99 -9.96 None
Bluebird bio Inc BLUE 712 54 0.86 -0.83 -246.75
Forma Therapeutics Holdings In FMTX 681 101 1.36 -4.81 -35.56
VBI Vaccines Inc. VBIV 680 1 4.37 -10.42 None
Agenus Inc AGEN 675 307 18.91 -3.50 1.23
Finch Therapeutics Group Inc FNCH 671 20 3.08 -12.97 -267.22
4D Molecular Therapeutics Inc FDMT 624 17 3.32 -9.39 -393.55
Aligos Therapeutics Inc ALGS 589 4 2.69 -4.68 None
Tarsus Pharmaceuticals Inc TARS 546 57 3.00 -50.98 -18.42
Aerie Pharmaceuticals Inc AERI 487 104 -6.73 -2.88 -159.84
ANI Pharmaceuticals Inc ANIP 482 212 2.99 -21.96 -10.40
Taysha Gene Therapies Inc TSHA 457 230 3.38 -4.14 30.39
Poseida Therapeutics Inc PSTX 448 3 3.01 -3.27 -658.69
Athira Pharma Inc ATHA 444 1.45 -31.88 None
SAB Biotherapeutics Inc SABS 444 78 4.20 26.46 21.49
Curis Inc CRIS 405 11 4.26 -10.84 -373.25
ImmunityBio Inc IBRX 405 179 0.72 16.62 13.55
Passage Bio Inc PASG 396 1.16 -2.27 None
Cel-Sci Corp. CVM 390 0 7.01 -11.20 -392.81
Cellular Biomedicine Group Inc CBMG 375 0 22.19 -7.00 -776.23
Jounce Therapeutics Inc JNCE 358 89 1.55 -54.36 -28.20
Lineage Cell Therapeutics Inc LCTX 330 3 2.86 -25.75 -386.75
SQZ Biotechnologies Co SQZ 328 17 2.47 -4.40 -432.38
PDL Biopharma Inc PDLI 289 52 0.67 -1.91 -297.95
Codiak Biosciences Inc CDAK 287 17 8.58 -4.04 -428.43
Fusion Pharmaceuticals Inc FUSN 235 1 0.98 -6.82 None
Apollo Endosurgery Inc APEN 219 60 133.86 -12.86 -29.80
Cardiff Oncology Inc CRDF 207 0 1.72 -9.58 -883.77
Eiger BioPharmaceuticals Inc EIGR 204 9 2.28 -6.44 -352.48
Harpoon Therapeutics Inc HARP 190 27 2.70 -1.86 -397.17
Aptose Biosciences Inc APTO 186 0 2.11 -3.37 None
Tcr2 Therapeutics Inc TCRR 186 0.63 -2.05 None
Outlook Therapeutics Inc OTLK 182 8 18.43 -5.16 -442.42
Adverum Biotechnologies Inc ADVM 172 8 0.50 -1.15 None
Solid Biosciences Inc SLDB 168 10 0.88 -2.18 -716.04
Adma Biologics Inc ADMA 158 69 2.58 -2.09 -108.60
AvroBio Inc AVRO 153 80 0.82 -1.28 0.43
Ayala Pharmaceuticals Inc AYLA 131 3 3.30 -3.26 -813.00
Atyr Pharma Inc LIFE 121 2 1.91 -3.99 -155.18
La Jolla Pharmaceutical Co. LJPC 118 74 -1.37 10.56 16.67
Fennec Pharmaceuticals Inc FENC 117 0 6.18 -7.28 -2.98
Champions Oncology Inc CSBR 116 43 14.84 517.00 0.27
Brainstorm Cell Therapeutics, BCLI 116 4.81 -3.77 None
CASI Pharmaceuticals Inc CASI 115 26 1.40 -2.49 -175.18
Voyager Therapeutics Inc VYGR 109 16 1.25 -1.16 -584.62
Armata Pharmaceuticals Inc ARMP 108 1 5.58 -4.50 -795.84
X4 Pharmaceuticals Inc XFOR 96 3 1.45 -1.11 None
LogicBio Therapeutics Inc LOGC 90 3 2.17 -2.55 -944.44
Genocea Biosciences Inc GNCA 87 2 1.88 -1.94 -766.21
Applied Genetic Technologies C AGTC 76 1 1.27 -1.31 -4.81
Pluristem Therapeutics Inc PSTI 75 0 1.64 -1.38 -816.51
Checkmate Pharmaceuticals Inc CMPI 74 0.89 -3.65 None
Protara Therapeutics Inc TARA 72 0.43 -1.74 None
Cidara Therapeutics Inc CDTX 70 46 -74.00 -1.45 -102.65
AIM ImmunoTech Inc AIM 65 0 1.10 -3.81 None
Xtant Medical Holdings Inc XTNT 61 55 1.95 3.70 -5.92
Aziyo Biologics Inc AZYO 47 49 6.10 -0.55 -43.11
BiomX Inc PHGE 43 0.91 -1.20 None
Caladrius Biosciences Inc CLBS 40 35 0.54 -1.23 -92.55
Inhibikase Therapeutics Inc IKT 40 3 0.92 -3.60 -335.03
Allena Pharmaceuticals Inc ALNA 38 2.06 -0.77 None
TRACON Pharmaceuticals Inc TCON 36 0 2.34 -1.57 -218.20
Windtree Therapeutics Inc WINT 36 0 0.92 -0.59 None
Protalix BioTherapeutics Inc. PLX 35 49 12.38 -1.89 -41.62
Organovo Holdings Inc ONVO 35 2 1.10 -3.23 -852.00
Microbot Medical Inc MBOT 34 0 1.94 -3.42 None
PolarityTE Inc PTE 32 12 1.36 -0.83 -265.02
Idera Pharmaceuticals, Inc. IDRA 29 1 0.97 -0.23 -236.98
Acorda Therapeutics Inc ACOR 26 130 0.18 -0.14 -127.77
Seneca Biopharma Inc SNCA 20 0 2.94 -1.42 None
Brickell Biotech Inc BBI 19 0 1.71 -0.58 -171.82
Titan Pharmaceuticals, Inc. (d TTNP 9 4 1.43 -0.69 -343.68
PharmaCyte Biotech Inc PMCB 5 0 8.79 -1.07 None
Teligent Inc TLGT 2 46 -0.08 -0.01 -197.78

Don’t Miss Out on this Buy-In Window for Alector Inc. (ALEC)

2d ago, source: investchronicle

At the end of the latest market close, Alector Inc. (ALEC) was valued at $19.35. In that particular session, Stock kicked-off at the price of $19.62 while reaching the peak value of $20.94 and lowest ...

Alector Inc. (NASDAQ: ALEC) Is A Great Opportunity For Risk-Tolerant Investors

13d ago, source: marketingsentinel

Alector Inc. (NASDAQ:ALEC)’s traded shares stood at 0.36 million during the last session. At the close of trading, the stock’s price was $21.39, to imply a decrease of -2.95% or -$0.65 in intraday ...

The Chart for Alector Inc. (ALEC) Is Flashing Mixed Signals

8d ago, source: newsheater

Alector Inc. (NASDAQ:ALEC) went up by 0.57% from its latest closing price compared to the recent 1-year high of $43.32. The company’s stock price has collected -4.23% of loss in the last five trading ...

Alector to Present New Data from Multiple Pipeline Programs at 2021 CTAD Conference and SITC Annual Meeting

29d ago, source: Yahoo

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced presentations at ...

Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer's 36th Annual Meeting

21d ago, source: Stockhouse

Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer's 36th ...

Alector Reports Third Quarter 2021 Financial Results

28d ago, source: Yahoo Finance

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today reported third quarter 2021 ...

Alector (ALEC) Lags Q3 Earnings and Revenue Estimates

7d ago, source: Business Insider

Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alector, Inc. (ALEC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks ...

Alector Presents New Data from Multiple Pipeline Programs at 2021 CTAD Conference

22d ago, source: Yahoo Finance

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, shared data from its AL003 and ...

Today's Top Movers

3d ago, source: U.S. News & World Report

Enochian Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment ...

Party City Holdco Inc (PRTY)

9d ago, source: Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and ...

Alector Reports Third Quarter 2021 Financial Results

29d ago, source: Benzinga.com

Nov. 04, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today reported third quarter 2021 financial results and ...

Alector to Present New Data from Multiple Pipeline Programs at 2021 CTAD Conference and SITC Annual Meeting

1mon ago, source: Middle East North Africa Financial Network

Nov. 03, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced presentations at the 14th Clinical Trials on ...

Your Portfolio